Betting big on talent, resources, and the ecosystem required for innovation and enterprise, Prime Minister Narendra Modi invited stakeholders to ideate in India, innovate in India and Make in India for the world
The US $ 192.5 mn US government contract will help fund the centre of excellence to boost the domestic supply of critically needed laboratory plastics
It is the world’s first DNA-based Covid vaccine
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland
In India, almost all approved vaccines are packed in FIOLAX glass made by SCHOTT
The Bidar API manufacturing facility of Sai Life Sciences has been on a path of significant expansion with its production capacity growing from 200KL in 2017 to 450KL
_256_384.jpeg)
The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio
Subscribe To Our Newsletter & Stay Updated
